Perspective: To use technology better

Health Affairs

Volumn 25, Issue 2, 2006, Pages

  Garber, Alan M ^a,b,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; BIOMEDICAL TECHNOLOGY ASSESSMENT; ECONOMICS; HEART INFARCTION; HUMAN; MASS COMMUNICATION; MEDICAL TECHNOLOGY; NOTE; REIMBURSEMENT; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; BIOMEDICAL TECHNOLOGY; DIFFUSION OF INNOVATION; HUMANS; MYOCARDIAL INFARCTION; REIMBURSEMENT, INCENTIVE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME; UNITED STATES;

EID: 33645698410     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.25.w51     Document Type: Review

References (8)

1. According to the late medical historian Roy Porter, "The breakthroughs of the last fifty years have saved more lives than those of any epoch since medicine began." R. Porter, The Greatest Benefit to Mankind: A Medical History of Humanity (New York: W.W. Norton, 1997), 715.
2. D.M. Cutler and M. McClellan, "Is Technological Change in Medicine Worth It?" Health Affairs 20, no. 5 (2001): 11-29;
3. and J.S. Skinner, D.O. Staiger, and E.S. Fisher, "Is Technological Change in Medicine Always Worth It? The Case of Acute Myocardial Infarction," Health Affairs 25 (2006): w34-w47 (published online 7 February 2006; 10.1377/hlthaff.25.w34).
4. See D.M. Cutler et al., "Are Medical Prices Declining? Evidence from Heart Attack Treatments," Quarterly Journal of Economics 113, no. 4 (1998): 991-1024.
5. Cutler and McClellan, "Is Technological Change in Medicine Worth It?"
6. This finding is at odds with data for all heart disease and all ages. U.S. age-adjusted mortality from heart disease fell as much in the six years from 1996 to 2002 as it had from 1984 to 1995. See National Center for Health Statistics, Health, United States, 2005 (Hyattsville, Md.: U.S. Government Printing Office, 2005), Table 36.
7. M.B. McClellan and D.P Kessler, eds., Technological Change in Health Care: A Global Analysis of Heart Attack (Ann Arbor: University of Michigan Press, 2002).
8. J.A. DiMasi, R.W. Hansen, and H.G. Grabowski, "The Price of Innovation: New Estimates of Drug Development Costs," Journal of Health Economics 22, no. 2 (2003): 151-185.